Our Customers
See why leading companies from around the world are empowered by JMP
Pharmaceutical
- PharmaronAn interview with Amy Hawksworth, Senior Manager of Downstream Process Sciences
- Eli LillyChao Richard Li on data literacy and DOE.
- AdociaStatistical approaches boost reproducibility and knowledge continuity in process transfer.
- SynthaceBiologists achieve all the benefits of sophisticated statistical methods without time-intensive programming.
- F-star TherapeuticsStatistical approaches to experimentation open the door to the exploration of novel biology.
- LonzaA customized design of experiments approach optimizes yield in bioreactors.
- GlaxoSmithKlineScientists and engineers improve production processes.
- Roche SwitzerlandRoche provides biosensors that allow health care professionals to get bedside readings of the quality of a patient’s blood.
- Siemens HealthineersQuality engineers optimize manufacturing, testing and performance of an innovative blood-analysis system.
- Beckman CoulterBeckman Coulter adapts to evolving regulatory standards while building in-house statistical capabilities.
- Colorado Department of Public Health and EnvironmentAn epidemiologist uses data analysis to help patients living with HIV/AIDS reenter the care continuum.
- CelltrionQuality by Design advances safety, affordability and regulatory accountability.
- Fujifilm Diosynth BiotechnologiesScientists use the Functional Data Explorer platform in JMP Pro to develop a cost-effective means to advance process knowledge in less time.
- Johnson Matthey BiocatalystsA forward-thinking statistical monitoring program helps ensure smooth and accurate regulatory filings.
- MedytoxA Korean biopharmaceutical trailblazer prepares to enter the global market by ‘strengthening internal infrastructure and improving clinical quality.’
- MerckBiostatisticians use interactive features in JMP to perform robust statistical analyses in less time.
- AlmirallData scientists build a data management standard for medical monitoring and regulatory compliance.
- Johnson Matthey Fine ChemicalsAt Johnson Matthey, JMP is the ‘active ingredient’ in process optimization
- De Montfort UniversityIndustry experts partner with the university to provide instruction on QbD best practices.
- Tillotts PharmaAnalysts at Tillotts Pharma AG rely on JMP statistical discovery software from SAS to explore drug stability data.
- ElancoAnalytics, visualization help Elanco clients produce more robust chickens.
- AB VistaAB Vista sees sustainable agriculture and peer-reviewed science as central to its mission.
- Ferring Pharmaceuticals & NNEJMP Clinical enables Ferring to implement a custom centralized statistical monitoring program designed by consultancy NNE.
- Roche UKA forward-thinking statistical monitoring program helps ensure smooth and accurate regulatory filings.
- London DNA FoundrySynthetic biologists improve experimentation with DOE and robotic automation.
- Pierre FabreJMP gives Pierre Fabre the tools to optimize its pharmaceutical and consumer health product lines.
- Mitsubishi Tanabe PharmaResearchers use JMP outputs to make pharmaceutical production processes more efficient and reliable.
- Mario Negri Institute for Pharmacological ResearchEpidemiologist uses JMP to study aging, anemia, Alzheimer's and more.
- Daewoong PharmaceuticalA quality control team uses JMP to identify the root cause of a critical manufacturing issue.
- JanssenScientists build a tool to better detect and evaluate potential adverse effects in the R&D process.
- PerrigoPerrigo reduces product variability and other inefficiencies by growing the use of statistical analysis in experimentation and testing
- Ono PharmaceuticalA statistical approach helps Ono Pharmaceutical build quality controls directly into manufacturing methods
- Stanford University School of MedicineResearcher uses JMP to explore associations between genetic markers.
- ArlendaArlenda uses JMP to help pharmaceutical companies establish more effective, less expensive development and manufacturing processes.
- IpsenBiologists investigate biomarkers critical to the development of new cancer therapeutics.
- CEA GrenobleResearchers save time on analysis, communication and technology transfer.